CClinicalTrials.gg
WithdrawnNCT07058532TWfCP&MHUpdated Sep 2, 2026

Therapeutic Writing for Adults Suffering From Chronic Pain and Comorbid Mental Health Disorders

An interventional study of Therapeutic Writing Intervention in Pain Rehabilitation in Chronic Pain, Mental Health Disorder and Psychiatric &Amp;Amp;or Mood Disorder, sponsored by Toni Salikka. Withdrawn at 1 site in Finland. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Toni Salikka · Not applicable, Interventional, and Treatment

Why this study was withdrawn
The collaborator could not proceed with the study due to personnel changes.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this observational study is to understand the effects and experiences of therapeutic writing interventions in adult women with chronic pain and co-occurring mental health conditions. The main questions it aims to answer are:

Can therapeutic writing help relieve chronic pain and emotional distress?

How does writing support emotional processing, regulation, and meaning-making during rehabilitation?

Participants will take part in a two-part writing intervention involving:

Guided writing exercises that focus on emotional processing, emotion regulation, and creating meaning.

Individual interviews after the writing sessions to explore their experiences.

The study uses qualitative analysis methods-phenomenology and logotherapy-to better understand how these writing interventions may support recovery, improve well-being, and offer non-pharmacological tools for managing chronic pain and mental health challenges.

Read the detailed description

Chronic pain affects approximately 20% of the global population and represents one of the most widespread causes of disability worldwide. Individuals living with chronic pain often experience additional mental health challenges-such as depression, anxiety, or trauma-related disorders-which compound their suffering and reduce quality of life. Traditional pain management strategies often focus on physical symptoms, while the emotional and psychological dimensions may remain under-addressed.

This study aims to explore the potential of therapeutic writing-a psychological intervention that encourages participants to express and process emotions through guided writing exercises-as a complementary approach for improving health and well-being in individuals with both chronic pain and mental health conditions.

The study is being conducted at the Department of Physical Medicine and Rehabilitation of Satasairaala Hospital in Finland and involves five adult female participants with chronic pain and comorbid psychiatric conditions. Each participant will engage in a two-part writing intervention that incorporates techniques grounded in emotional processing, emotion regulation, and meaning-making. These exercises are designed to help individuals articulate their internal experiences, explore the personal impact of pain and illness, and foster a sense of psychological coherence.

Data collection spans two sub-studies:

Sub-studies 1 and 2 involve qualitative interviews with participants following the intervention, capturing their firsthand experiences and perceived effects.

The qualitative data will be analyzed using a multi-method approach, combining phenomenological analysis-which highlights the participants' lived experiences-and logotherapy-informed analysis, which examines how therapeutic writing supports the search for meaning during rehabilitation. This dual approach provides a comprehensive view of how narrative expression may influence recovery pathways.

The ultimate goal is to identify writing-based strategies that can complement clinical care for this patient population and inform future updates to rehabilitation programs and treatment guidelines-both locally and nationally. If proven beneficial, therapeutic writing could serve as an accessible, cost-effective, and non-pharmacological tool to enhance holistic pain care and mental health support.

02

Conditions studied

  • Chronic Pain
  • Mental Health Disorder
  • Psychiatric &Amp;Amp;or Mood Disorder
  • Psychiatric Comorbidities
  • Psychiatric Diagnosis
  • Emotional Pain
  • Emotional Distress
  • Emotion Regulation
  • Emotional Processing
  • Meaning of Life
  • Meaning Made
  • Meaning of Life and Life Satisfaction
  • Depressive Disorder
  • Anxiety Disorders
  • Sleep Disorder
  • Comorbid Depression
  • Process, Acceptance

Keywords

  • Therapeutic writing
  • Chronic pain
  • Mental health disorders
  • Psychiatric disorders
  • Emotion regulation
  • Emotional processing
  • Meaning-making
  • Non-pharmacological intervention
  • Logotherapy
  • Phenomenological analysis
  • Psychosocial rehabilitation
  • Pain management
  • Pain coping
  • Creative writing
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

Browse Chronic Pain studies →

Lead sponsor

This is the only study on the registry with Toni Salikka as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Adult women (18 years or older), assigned female at birth and self-identify as women
  • Diagnosed with or experience of chronic, widespread (non-cancer) pain lasting at least two years
  • Diagnosed with or living with one or more mild mental health disorders (e.g., anxiety, mild depression), without current or past severe psychiatric conditions
  • Diagnosed with or experience of nociplastic pain (e.g., fibromyalgia)
  • Not currently using medications that may impair cognitive functioning (e.g., benzodiazepines, anticholinergics, opioids, antipsychotics)
  • Able to attend approximately 11 in-person visits over a 3-month period
  • Willing and able to participate in a structured therapeutic writing intervention
  • Purposefully selected to reflect a range of lived experiences relevant to the study's aims

Exclusion criteria

Exclusion Criteria:

  • Presence of severe mental health disorders (e.g., schizophrenia, bipolar disorder, severe depression, or other psychotic conditions)
  • Use of medications known to impair memory, attention, or decision-making (e.g., benzodiazepines, anticholinergics, opioids, antipsychotics)
  • Participation in other concurrent treatments that may influence study outcomes
  • Cognitive limitations that would hinder meaningful engagement in the writing intervention
  • Individuals not assigned female at birth or who do not identify as women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Therapeutic Writing Intervention in Pain Rehabilitation

    Participants in this single-arm study will take part in a structured therapeutic writing intervention as part of a multidisciplinary pain rehabilitation program at the Pain Clinic of Satasairaala Hospital. The study spans approximately three months and includes around 11 clinic visits. The intervention is delivered in two phases: first, four consecutive daily writing sessions (20 minutes each), followed by four weekly sessions (30-60 minutes each). Prior to the intervention, participants are assessed for eligibility by the clinic's multidisciplinary team and interviewed by the principal investigator. Post-intervention, participants are interviewed twice to explore their health-related experiences with the writing process.

    Other: Therapeutic Writing Intervention in Pain Rehabilitation

Interventions

  • OtherTherapeutic Writing Intervention in Pain Rehabilitation

    The therapeutic writing intervention is designed to support emotional processing and regulation in individuals with chronic pain and comorbid mental health disorders. It has been developed specifically for use in a clinical rehabilitation setting and is delivered in two phases over a four-week period at the Pain Clinic of Satasairaala Hospital. Sessions are conducted in person, with clinical staff available to support participants. The intervention is non-pharmacological, low-risk, and integrated into the broader multidisciplinary care pathway.

06

What researchers measure

Primary outcomes

  1. Health-Related Experiences of Participants

    Description: Qualitative themes identified from semi-structured interviews exploring participants' perceived health-related changes following the writing intervention, including emotional processing, emotion regulation, and meaning-making. Unit of Measure: Thematic categories derived from qualitative content analysis. Time Frame: Data will be collected through semi-structured interviews conducted at three time points: prior to the writing intervention (baseline), immediately after the final writing session (Week 5), and three months after the intervention (Week 17).

    Time frame: Baseline (prior to intervention), immediately post-intervention (Week 5), and 3 months post-intervention (Week 17)

Secondary outcomes

  1. Perceived Impact on Emotion Regulation

    Participant-reported changes in emotional awareness, expression, and regulation, identified through qualitative analysis of semi-structured interviews conducted immediately post-intervention. Original Unit of Measure: Thematic categories and frequency of emotion regulation-related content identified through qualitative content analysis. Time Frame: Data will be collected through semi-structured interviews conducted at three time points: prior to the writing intervention (baseline), immediately after the final writing session (Week 5), and three months after the intervention (Week 17).

    Time frame: Baseline (prior to intervention), immediately post-intervention (Week 5), and 3 months post-intervention (Week 17)

  2. Themes of Meaning-Making and Future Orientation Identified Through Qualitative Interview Analysis

    Description: Themes related to personal meaning, future goals, and psychological growth will be assessed through qualitative content analysis of semi-structured interviews conducted at three time points: baseline, immediately post-intervention (Week 5), and 3 months post-intervention (Week 17). Unit of Measure: Thematic categories and depth of meaning-making and future orientation content identified through qualitative content analysis. Time Frame: Baseline (prior to intervention), immediately post-intervention (Week 5), and 3 months post-intervention (Week 17)

    Time frame: Baseline (prior to intervention), immediately post-intervention (Week 5), and 3 months post-intervention (Week 17)

07

Study locations

1 site
  • Satasairaala Hospital, Department of Physical Medicine and Rehabilitation: Pain Clinic
    Pori, Satakunta 28500, Finland
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared due to privacy and confidentiality concerns. The data includes sensitive personal information that cannot be fully anonymized without risking participant identification.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07058532
Lead sponsor
Toni Salikka
Responsible party
Toni Salikka (MA, PhD Candidate, Tampere University) — Sponsor-investigator
First posted
Jul 10, 2025
Start date
Sep 2025 (estimated)
Primary completion
Apr 2026 (estimated)
Completion
Apr 2026 (estimated)
Last update
Sep 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion